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Question: For people with plantar fasciopathy, is a 12-week self-dosed heavy-slow resistance training
program more beneficial than a 12-week pre-determined heavy-slow resistance training program?
Design: A randomised trial with concealed allocation, partial blinding, and intention-to-treat analysis.
Participants: Seventy people with plantar fasciopathy confirmed on ultrasonography. Intervention: Both
groups performed a repeated heel raise exercise in standing for 12 weeks. Participants in the experimental
group were self-dosed (ie, they performed as many sets as possible with as heavy a load as possible, but no
heavier than 8 repetition maximum). The exercise regimen for the control group was pre-determined (ie, it
followed a standardised progressive protocol). Outcome measures: The primary outcome was the Foot
Health Status Questionnaire pain domain. Secondary outcomes included: a 7-point Likert scale of Global
Rating of Change dichotomised to ‘improved’ or ‘not improved’; Patient Acceptable Symptom State defined as
when participants felt no further need for treatment; and number of training sessions performed. Results:
There was no significant between-group difference in the improvement of Foot Health Status Question-
naire pain after 12 weeks (adjusted MD 26.9 points, 95% CI 215.5 to 1.7). According to the Global Rating of
Change, 24 of 33 in the experimental group and 20 of 32 in the control group were improved (RR = 1.16, 95%
CI 0.83 to 1.64). Only four participants achieved Patient Acceptable Symptom State: three of 35 in the
experimental group and one of 35 in the control group. No significant between-group difference was found in
the number of training sessions that were performed (MD 22 sessions, 95% CI 28 to 3). Conclusion: Self-
dosed and pre-determined heavy-slow resistance exercise programs are associated with similar effects on
plantar fasciopathy pain and other outcomes over 12 weeks. Advising people with plantar fasciopathy to self-
dose their slow-heavy resistance training regimen did not substantially increase the achieved dose compared
with a pre-determined regimen. These regimens are not sufficient to achieve acceptable symptom state in
the majority of people with plantar fasciopathy. Registration: ClinicalTrials.gov NCT03304353. [Riel H,
Jensen MB, Olesen JL, Vicenzino B, Rathleff MS (2019) Self-dosed and pre-determined progressive heavy-
slow resistance training have similar effects in people with plantar fasciopathy: a randomised trial.
Journal of Physiotherapy 65:144–151]
© 2019 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Plantar fasciopathy is one of the most prevalent musculoskeletal
conditions and will affect one in every ten people during their life-
time.1 The condition was formerly labelled as ‘plantar fasciitis’ but
due to histological findings similar to those of tendinopathies, long-
standing plantar fasciopathy is now considered a tendinopathy.2–4
The condition is characterised by severe and well-localised pain
that often persists for several months or even years.5 People with
plantar fasciopathy report pain during the first steps in the morning
or after inactivity, which improves with ambulation and worsens
during the day.6 Runners and 40 to 60-year-old people with low. Published by Elsevier B.V. This is
onymous User (n/a) at Aalborg Hos
nly. No other uses without permissactivity levels and high body mass index are the most prone to
plantar fasciopathy.7,8 The condition also affects mental health and as
many as one in five people will have several days of sick leave due to
their pain.9–11
A recent systematic review and network meta-analysis evaluated
the comparative effectiveness of commonly used treatments for
plantar fasciopathy and none was superior to any other.12 A new
approach not included in that review is heavy-slow resistance
training, which involves repeated slow contractions through
concentric, isometric and eccentric phases against a heavy load.
Heavy-slow resistance training is often used for other tendinopathies,
despite uncertainty about the optimal regimen.13–17 Preliminaryan open access article under the CC BY-NC-ND license (http://creativecommons.org/
pital from ClinicalKey.com by Elsevier on July 23, 2019.
ion. Copyright ©2019. Elsevier Inc. All rights reserved.
Table 1
Mechanobiological descriptors of the exercise interventions.
Descriptor Exercise programs
Experimental Control
Load magnitude As heavy as possible, but no heavier than a
weight that can be lifted at least 8 times (8RM)
Week 112: 12RM
Week 314: 10RM
Week 51: 8RM
Number of repetitions  8 depending on the load Week 112: 12
Week 314: 10
Week 51: 8
Number of sets As many as possible Week 112: 3
Week 314: 4
Week 51: 5
Rest between sets 2 min
Session frequency 3.5/week
Duration of program 12 weeks
Contraction modes within one repetition 3 s concentric, 2 s isometric, 3 s eccentric
Rest between repetitions Nil
Time under tension 8 s/repetition,  64 s/set,  64 s/training session
Total over 12 weeks: varies between participants
depending on number of sets performed
Week 112: 8 s/repetition,
96 s/set, 288 s/training session
Week 314: 8 s/repetition,
80 s/set, 320 s/training session
Week 51: 8 s/repetition,
64 s/set, 320 s/training session
Total over 12 weeks: 13 216 s
Volitional muscular failure Yes
Range of motion Full range of motion
Recovery between sessions 48 hours
Anatomical definition of the exercise (exercise form) The participant stood with the forefoot on a step. A towel was placed underneath the toes to dorsiflex
them throughout the exercise. With a fully extended knee, the participant performed a heel raise to
maximal plantarflexion in the ankle joint and afterwards lowered the heel to maximal dorsiflexion.
Support for balance by placing the hands on a wall or a rail was allowed.
RM = repetition maximum.
Research 145evidence found heavy-slow resistance training to be superior to
stretching in plantar fasciopathy,18 but the exercise dose was far
lower than that prescribed in trials of other tendinopathies.15,17,19–22
Increasing exercise dose could lead to greater improvement in out-
comes through a greater mechanobiological stimulus.23 One way to
increase dose is to prescribe a larger exercise dose, but compliance is
often compromised by low self-efficacy.24,25 An alternative approach
is to encourage patients to be in charge of their own rehabilitation
and thereby increase exercise dose through increased self-efficacy.
Therefore, the research question for this randomised trial was:
For people with plantar fasciopathy, is a 12-week self-dosed
heavy-slow resistance training program more beneficial than a
12-week pre-determined heavy-slow resistance training
program?Method
Study design
A randomised trial was conducted with concealed allocation,
partial blinding and intention-to-treat analysis. Two 12-week heavy-
slow resistance training regimens – one self-dosed and one pre-
determined – were compared in people with plantar fasciopathy.
Prior to recruitment the trial protocol, template informed consent
forms and participant information were approved by the Ethics
Committee of the North Denmark Region in accordance with the
Declaration of Helsinki.26 People provided written informed consent
before enrolment. Reporting followed CONSORT and TIDieR guide-
lines.27–29 The trial planning was performed in accordance with theDownloaded for Anonymous User (n/a) at Aalborg Hospital f
For personal use only. No other uses without permission. CoPREPARE Trial guide.30 Before inclusion of the first participant, the
trial was registered on clinicaltrials.gov, where the trial protocol was
made publicly available.
Participants, therapist, centre
People with plantar fasciopathy were recruited through Facebook
advertisement or by referral from their general practitioner. Tele-
phone screening was performed and individuals who fulfilled the
criteria were invited to a clinical examination at the Research Unit for
General Practice in Aalborg, Denmark. The primary investigator –
who was responsible for inclusion, exercise instructions and data
collection – was a registered physiotherapist with 6 years of experi-
ence in treating patients with musculoskeletal disorders. Inclusion
criteria were: history of inferior heel pain for at least 3 months before
enrolment; pain on palpation of the medial calcaneal tubercle or the
proximal plantar fascia; thickness of the plantar fascia of  4.0 mm;
and mean heel pain  20 mm on a 100-mm visual analogue scale
during the previous week.31 Exclusion criteria were: age , 18 years;
diabetes; inflammatory systemic diseases;31 pregnancy; prior heel
surgery; or corticosteroid injection for plantar fasciopathy within the
previous 6 months.
Randomisation
After eligibility had been confirmed, participants were stratified
by gender and block randomised (block sizes of two to six) at 1:1 to
the experimental group or the control group. A researcher not
involved in the trial generated the allocation sequence using a
random number generator on www.sealedenvelope.com and was the
only person who knew the block sizes. After enrolment, the primaryrom ClinicalKey.com by Elsevier on July 23, 2019.
pyright ©2019. Elsevier Inc. All rights reserved.
146 Riel et al: Self-dosed versus pre-determined heavy-slow resistance traininginvestigator opened a sequentially numbered, opaque, sealed enve-
lope in which the participant’s group allocation was found.
Interventions
Both groups received standardised patient education, a silicone
heel cup, and performed either a self-dosed or a pre-determined non-
supervised exercise program.
Participants were told that the trial was about exercise for treating
plantar fasciopathy and that there would be two groups that per-
formed exercises in different ways. They were blinded to which of the
outcomes was the primary outcome and to the differences between
the heavy-slow resistance training programs.
Both groups were informed about plantar fasciopathy in terms of
risk factors, aetiology, pathology, and were informed that heavy-slow
resistance training was superior to stretching in plantar fasciopathy.
Participants in the pre-determined group were informed that it was
important to follow the program as closely as possible, whereas
participants in the self-dosed group were told that (based on research
on other tendinopathies) it was believed that performing the exercise
as heavily as possible, but no heavier than 8 repetition maximum
(RM), and with as many sets as possible would increase the likelihood
of recovery. Both groups were told that compliance with their pro-
gram was very important and associated with recovery. Participants
were told that pain during exercise was not associated with tissue
damage and that there was no upper limit of pain during exercise, as
long as it was tolerable. The aim of this was to reduce any potential
fear of exercise-related pain. Participants were advised to decrease
their physical activity level and slowly rebuild it depending on their
symptoms. They were also advised that it was acceptable to partici-
pate in physical activities that did not exacerbate symptoms that
outlasted the activity. If participants already used a foot orthosis, they
were allowed to continue wearing this if they did not want to use the
heel cup. No concomitant treatments were allowed. Participants were
contacted either by telephone or by e-mail 2 weeks after inclusion to
ask if they had experienced difficulties with the exercise and to
encourage them to continue the intervention.
Heavy-slow resistance training
Both groups performed standing heel raises. Participants in the
experimental group were instructed to perform the exercise with the
load as heavy as possible but no heavier than 8RM and for as many
sets as possible. Participants in the control group were instructed to
perform the exercise according to a rigid protocol progressing from
12RM to 8RM. This progressive protocol was similar to the protocol
used by Rathleff et al,18 where heavy-slow resistance training was
found to be superior to plantar fascia stretching. Both groups per-
formed exercises every second day during the 12-week intervention.
The exercise descriptors are displayed in Table 1.32 If participants felt
they could perform more repetitions than their load corresponded to
(eg, 10 repetitions when the load was supposed to be 8RM), a back-
pack with books to add weight was used.
Outcome measures
The primary outcome was change in the Foot Health Status
Questionnaire (FHSQ) pain domain from Week 0 to Week 12. The
FHSQ is a self-report questionnaire ranging from 0 (poor foot health)
to 100 (optimum foot health) that assesses multiple dimensions of
foot health and function across four domains with a total of 13 items
and has a high reliability (ICC = 0.74 to 0.92).33 Responses were
entered into the FHSQ software, which calculated scores for each
domain. A validated Danish translation of the FHSQ was used.34
Secondary outcomes included: the function, footwear and general
foot health domains of the FHSQ; Global Rating of Change; plantar
fascia thickness measured in millimetres; exercise compliance; Pain
Self-Efficacy Questionnaire; Patient Acceptable Symptom State; and
physical activity level measured by the International Physical Activity
Questionnaire short version. All questionnaires were completed at
Weeks 0, 4 and 12. The Global Rating of Change was collected at WeekDownloaded for Anonymous User (n/a) at Aalborg Hospi
For personal use only. No other uses without permissio12 and was used to measure participants’ self-reported improvement
on a 7-point Likert scale ranging from ‘much improved’ to ‘much
worse’. Participants were categorised as improved if they rated
themselves as ‘much improved’ or ‘improved’ (categories 6 or 7) and
categorised as not improved if they rated themselves from ‘slightly
improved’ to ‘much worse’ (categories 1 to 5). Plantar fascia thickness
was measured using ultrasonography at Weeks 0, 4 and 12. The
participant lay prone with the toes maximally dorsiflexed on the
examination table and a longitudinal scan was performed. An average
of three measurements was used. This method has been found to be
reliable in a previous study (ICC = 0.67 to 0.77).35 Compliance was
estimated based on the number of training sessions performed
throughout the intervention, according to a training diary that par-
ticipants were given at baseline. Patient Acceptable Symptom State
was defined as when participants achieved a self-evaluated satisfac-
tory result and felt that no further treatment was needed; hence, it
was not necessarily a measure of complete recovery.36–38 The Pain
Self-Efficacy Questionnaire was used to measure change in self-
efficacy; it ranges from 0 to 60, with lower scores indicating lower
self-efficacy.39 A reliable Danish validated translation of the ques-
tionnaire was used (ICC = 0.89).40 The International Physical Activity
Questionnaire short version was used to estimate time spent per-
forming vigorous and moderate activities, and time spent walking
during the past week measured in metabolic equivalent of task
(MET)-minutes.41,42
Data analysis
Sample size was based on the ability to detect a minimum clini-
cally important between-group difference at the 12-week follow-up
of 14.1 points in FHSQ pain.43 Based on a standard deviation of 20
points (comparable with standard deviations found in previous
studies of this population),31,44,45 a two-sided 5% significance level
and a power of 80%, a sample size of 33 participants in each group
was required. Taking into consideration that drop-outs may occur, 70
participants were included.
Statistical analyses were performed according to a pre-established
analysis plan in consultation with a statistician and using commercial
software.a Q-Q plots were used to assess data distribution. The pri-
mary intention-to-treat analysis tested between-group difference in
FHSQ pain at the 12-week follow-up using a repeated measures
ANCOVA with the outcome as the dependent variable, time (4 weeks
and 12 weeks) as the within-subjects factor, group allocation as the
between-subjects factor, and the baseline value as the covariate.46
The same model was used to perform between-group comparisons
of the other FHSQ domains, Pain Self-Efficacy Questionnaire, and
plantar fascia thickness, with the respective outcome as the depen-
dent variable. Due to non-normal distribution of the data, the
between-group difference in the International Physical Activity
Questionnaire short version was investigated using Mann-Whitney U
test. The between-group difference in the number of training sessions
performed was tested using independent t-tests. The relative risk
(RR) was calculated for the dichotomised Global Rating of Change and
the dichotomised Patient Acceptable Symptom State. Associations
between Pain Self-Efficacy Questionnaire score and compliance, FHSQ
pain score and plantar fascia thickness, and the association between
compliance and FHSQ pain score were investigated using Pearson’s
correlation coefficient. In an intention-to-treat analysis, multiple
imputation was used to handle missing outcome data and estimates
from 10 imputed data sets were combined using Rubin’s Rules.47 A
complete case analysis only including cases with no missing outcome
data was performed as a sensitivity analysis.Results
Compliance with the study protocol
All participants received the intervention (ie, prescription of their
heavy-slow resistance training regimen) as randomly allocated. Alltal from ClinicalKey.com by Elsevier on July 23, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
Assessed for eligibility (n = 91)
• recruited from Facebook (n = 86)
• recruited from general practitioner (n = 5)
Excluded (n = 21) 
• unable to contact (n = 5)
• diabetes (n = 3)
• pain <20mm on VAS (n = 2) 
• plantar fascia thickness <4mm (n = 2) 
• corticosteroid injection for plantar 
fasciopathy within past 6 months (n = 2)
• lived too far away (n = 2)
• refused participation (n = 2)
• symptom duration <12 weeks (n = 1)
• rheumatoid arthritis (n = 1)
• married to another participant (n = 1)
Measured Foot Health Status Questionnaire, plantar fascia thickness, Pain Self Efficacy  
Questionnaire, and International Physical Activity Questionnaire
Randomised (n = 70)
(n = 35) (n = 35) 
Week 0
Experimental group 
•patient education 
•silicone heel cup
•self-dosed regimen of heel 
raise exercises: maximum
tolerated sets and  
resistance, with resistance 
no heavier than 8RM
•12 weeks
Week 4
Measured Foot Health Status Questionnaire, plantar fascia thickness, Pain Self Efficacy 
Questionnaire, International Physical Activity Questionnaire and Patient Acceptable Symptom
State
(n = 33) (n = 33)
Week 12
Lost to follow-up
• symptoms
worsened (n = 1)
• pregnant (n = 1)
Lost to follow-up
(n = 0) 
Control group 
•patient education
•silicone heel cup 
•pre-set regimen of
heel raise exercises: 
fixed repetitions and 
progression from
12RM to 8RM
Lost to follow-up
• did not arrive
for final visit
(n = 1)
Lost to follow-up
• symptoms
worsened (n = 1) 
• lack of time (n = 1) 
Measured Foot Health Status Questionnaire, plantar fascia thickness, Pain Self Efficacy  
Questionnaire, International Physical Activity Questionnaire, Patient Acceptable Symptom
State and Global Rating of Change
(n = 33) (n = 33)
•12 weeks
Figure 1. Design and flow of participants through the trial.
RM = repetition maximum, VAS = visual analogue scale.
Research 147registered outcomes were measured. However, 20 of 70 training di-
aries could not be retrieved.Flow of participants through the study
A total of 91 individuals were interested in participation (Figure 1).
Seventyparticipantswere enrolled fromOctober2017 to February2018,
and the last 12-week follow-upwas conducted inMay2018.Clinical and
demographic baseline characteristics of the two groups were similar
(Table 2). Fourteen participants (23% of those participants who had
previously been in the workforce) reported that they had taken be-
tweenone and200days offwork due to plantar fasciopathy (median 30
days). Participants had consulted their general practitioner in 48 casesDownloaded for Anonymous User (n/a) at Aalborg Hospital f
For personal use only. No other uses without permission. Co(69%) and 28 participants (40%) had consulted a physiotherapist. Foot
orthoses were the most common treatment that participants had tried
before enrolment (37 participants, 53%), with strengthening exercises
including heel raises being the second most common treatment (36
participants, 51%). A full table of treatments and healthcare practi-
tioners consulted is in Appendix 1 on the eAddenda.Primary outcome
There was no significant between-group difference in the
improvement of FHSQ pain after 12 weeks (adjusted MD 27 points,
95% CI 216 to 2), as presented in Table 3 and Figure 2. The upper limit
of the confidence interval (ie, the estimate that most favours self-rom ClinicalKey.com by Elsevier on July 23, 2019.
pyright ©2019. Elsevier Inc. All rights reserved.
Table 2
Baseline characteristics of all participants.
Characteristic Randomised (n = 70)
Exp
(n = 35)
Con
(n = 35)
Age (yr), mean (SD) 50 (10) 49 (12)
Gender, n female (%) 29 (83) 29 (83)
Height (cm), mean (SD) 169 (10) 170 (8)
Mass (kg), mean (SD) 85 (16) 90 (19)
Body mass index (kg/m2), mean (SD) 29.9 (6.3) 30.7 (5.5)
Symptom duration (month), median (IQR) 9 (6 to 30) 8 (5 to 22)
Pain severity (0 to 100), mean (SD) a 62 (24) 63 (19)
Bilateral pain, n (%) 12 (34) 19 (54)
Plantar fasciopathy episodes (n), median (IQR) 1 (1 to 2) 1 (1 to 2)
Additional pain sites (n), median (IQR) b 3 (1 to 6) 3 (1 to 5)
a Average during previous week.
b Includes the entire body and head, and are derived from a pain manikin that
participants used during baseline assessment.59
148 Riel et al: Self-dosed versus pre-determined heavy-slow resistance trainingdirected dosing but remains consistent with the data collected) was 2,
which was below the minimum clinically important difference in the
prospective sample size calculation.Secondary outcomes
Almost all between-group differences were non-significant at
either assessment time point for the other three domains of the FHSQ
(ie, function, footwear, and general foot health), as presented in
Table 3. One result did reach statistical significance (footwear domain
at Week 12). This result favoured the control group (adjusted MD 26
points). The confidence interval retained effects that were very close
to no effect (0.2, rounded to 0 in Table 3). Again, none of the confi-
dence intervals contained an effect that exceeded the same clinically
worthwhile threshold in favour of the experimental group. Plantar
fascia thickness and the Pain Self-Efficacy Questionnaire were also
not significantly different between the groups (Table 3).
Data for the four measures derived from the International Physical
Activity Questionnaire short version (ie, walking, moderate activity,
vigorous activity and total activity) were not normally distributed,
with most participants achieving low activity and a few achieving
high activity. Most of the non-parametric comparisons showed sta-
tistically non-significant median differences between the groups
(Table 4). The result for walking at Week 4 was significantly different
in favour of the control group, with an unadjusted difference in
medians of 759 MET (p = 0.013). However, the difference was no
longer statistically significant at Week 12. Individual participant data
used in the analyses in Tables 3 and 4, as well as for all the remaining
outcomes, are presented in Table 5 on the eAddenda.
When participants provided a Global Rating of Change, 24 of 33 in
the experimental group and 20 of 32 in the control group wereTable 3
Mean (SD) of groups and adjusted mean (95% CI) between-group differences for Foot Health
Outcome Groups
Week 0 Week 4
Exp
(n = 35)
Con
(n = 35)
Exp
(n = 35)
Con
(n = 3
FHSQ pain
(0 to 100)
43
(17)
38
(16)
58
(16)
50
(18
FHSQ function
(0 to 100)
61
(23)
58
(21)
78
(23)
75
(19
FHSQ footwear
(0 to 100)
48
(16)
48
(15)
50
(16)
48
(16
FHSQ general foot health
(0 to 100)
51
(16)
55
(18)
53
(14)
50
(15
Plantar fascia thickness
(mm)
6.1
(1.2)
5.9
(1.2)
5.9
(1.3)
5.9
(1.3
PSEQ
(0 to 60)
44
(12)
45
(12)
50
(9)
47
(12
Con = control group = pre-determined regimen, Exp = experimental group = self-dosed regi
Shaded row = primary outcome.
Downloaded for Anonymous User (n/a) at Aalborg Hospi
For personal use only. No other uses without permissiocategorised as ‘improved’. This was a non-significant difference be-
tween the groups, with a relative risk of 1.16 (95% CI 0.83 to 1.64).
Only four participants improved enough to meet the Patient
Acceptable Symptom State definition: three of 35 in the experimental
group and one of 35 in the control group. Although the relative risk
indicated that the experimental group were 3.0 times more likely to
achieve Patient Acceptable Symptom State, this was not statistically
significant (95% CI 0.33 to 27).
The self-dosed group completed 36 training sessions (SD 8) and
the pre-determined group completed 34 training sessions (SD 12),
with a mean difference of 22 sessions (95% CI 28 to 3). The lowest
number of training sessions performed was three and the second
lowest was 13. Both participants were randomised to the pre-
determined group. The self-dosed group performed an average of
5.0 sets per training session (SD 2.8) whereas 4.5 sets per training
session were prescribed in the pre-determined program.
There was no significant association observed between: baseline
Pain Self-Efficacy Questionnaire and number of training sessions
performed (r =20.030, p = 0.837); change in FHSQ pain and change in
plantar fascia thickness (r = 20.234, p = 0.084); or change in FHSQ
pain and number of training sessions performed (r = 20.082, p =
0.570).
Four participants reported adverse events, but none related to
performing the exercise. All were non-serious musculoskeletal in-
juries of the lower extremities.
Complete case sensitivity analysis
The sensitivity analysis, which included only cases with no
missing 12-week FHSQ pain data, had similar results as the primary
analysis (MD 27 points, 95% CI 216 to 3). The multiply imputed
analysis and the complete case analysis found conflicting results in
two analyses. A significant between-group difference in FHSQ foot-
wear at Week 12 was found to be non-significant in the complete case
analysis (p = 0.057). A non-significant between-group difference in
the Pain Self-Efficacy Questionnaire at Week 4 was found to be sig-
nificant (p = 0.039); however, the difference was less than the mini-
mum clinically important change.48Discussion
This was the first trial comparing the efficacy between a self-
dosed and a pre-determined heavy-slow resistance training pro-
gram. A 12-week self-dosed heavy-slow resistance training program
did not reduce pain more than a pre-determined heavy-slow resis-
tance training program that has previously been shown to be effec-
tive.18 The self-dosed program was not associated with larger
improvements in self-efficacy or larger exercise dose during the trial.Status Questionnaire, plantar fascia thickness and the Pain Self-Efficacy Questionnaire.
Adjusted mean between-group
difference (95% CI)
Week 12 Week 4 minus
Week 0
Week 12 minus
Week 0
5)
Exp
(n = 35)
Con
(n = 35)
Exp minus Con Exp minus Con
)
70
(16)
62
(21)
27
(215 to 1)
27
(216 to 2)
)
89
(12)
84
(19)
21
(28 to 6)
24
(211 to 3)
)
52
(16)
46
(16)
22
(29 to 4)
26
(211 to 0)
)
49
(16)
54
(14)
24
(211 to 2)
5
(22 to 12)
)
5.7
(1.3)
5.6
(1.3)
0.2
(20.3 to 0.7)
0.1
(20.4 to 0.6)
)
54
(6)
51
(12)
23
(27 to 0)
23
(27 to 1)
men, FHSQ = Foot Health Status Questionnaire, PSEQ = Pain Self-Efficacy Questionnaire.
tal from ClinicalKey.com by Elsevier on July 23, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
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Figure 2. Pain domain of the Foot Health Status Questionnaire (FHSQ) by time.
The experimental group was allocated self-dosed heavy-slow resistance training and
the control group was allocated a pre-determined heavy-slow resistance training
regimen. Symbols show means and error bars show standard deviations. Lines join
group means at baseline and at Weeks 4 and 12. Experimental and control group data
have been offset slightly for clarity.
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Research 149Both groups had improvements in FHSQ pain larger than the
minimum clinically important difference, but only three of 35 in the
self-dosed group and one of 35 in the pre-determined group achieved
Patient Acceptable Symptom State, indicating continued need for
improved treatments for this long-term pain complaint.
The differences between the two exercise programs were mostly
not statistically significant and the confidence intervals largely
excluded effects that would be considered clinically worthwhile.43
The few statistically significant results could well have been Type-I
errors (ie, chance findings). This aligns with the findings from a
study in rotator cuff tendinopathy where a self-dosed single-exercise
program had effects that were equivalent to those of usual physio-
therapy, which mostly consisted of resistance exercises.20 Although
the self-dosed approach was used with the intention of increasing
self-efficacy and exercise dose, participants in the experimental group
did not perform more training sessions or sets per training session
(5.0 versus 4.5 sets) compared with the control group who undertook
the pre-determined regimen. Both groups demonstrated high exer-
cise compliance (on average two sessions per week).25,49 The exper-
imental and control programs appear to be two different ways of
achieving the same exercise dose and clinical results. Although pre-
vious studies have indicated an association between exercise dose
and recovery,50,51 this association was not observed in the present
trial; however, it should be noted that the analyses of correlations
may not have been reliable due to the present trial’s sample size.
The results of the present trial raise the question of whether there
is a role for heavy-slow resistance training in plantar fasciopathy
management. The magnitude, frequency, and duration of cyclic
strains are all important for the response and adaptation of both
muscle and connective tissue such as the plantar fascia.32 It is
possible that the load some participants used was inadequate to lead
to an adaptation. If pain during exercise set an upper limit of load
rather than muscular strength, adaptation could have been
hampered. Pain during this specific exercise has previously been re-
ported to be 42 mm on a 100-mm visual analogue scale and kinesi-
ophobia is a recognised feature in individuals with plantar
fasciopathy.11,52 It remains unknown if using a higher load would lead
to better recovery in plantar fasciopathy.
Even though both groups improved more than the nominated
minimum clinically important difference on the FHSQ pain domain
and the majority were improved according to the Global Rating of
Change, few achieved Patient Acceptable Symptom State. When
compared with other studies using FHSQ pain as an outcome, the
level of improvement is comparable to that of foot orthoses, taping,
corticosteroid injections, and even sham orthoses and placeboDownloaded for Anonymous User (n/a) at Aalborg Hospital from ClinicalKey.com by Elsevier on July 23, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
150 Riel et al: Self-dosed versus pre-determined heavy-slow resistance traininginjections.31,44,45 Therefore, the improvement seen in the present trial
could have derived from regression to the mean or the silicone heel
cups or patient education that participants received.53
Loading programs for other tendinopathies are usually pre-
determined, but our findings suggest there is no need for a
standardised program if patients are advised to maximise their rep-
etitions and load (up to 8RM) because such a self-dosed program led
to similar results.13,15,18,21,22 Physiotherapists might discuss the two
forms of exercise program prescription (self-dosed or pre-
determined) to determine whether one appeals to the individual
patient as being more motivating or acceptable. Heavy-slow resis-
tance training provides clinicians with an alternative to other con-
servative treatments in plantar fasciopathy but the effects compared
to wait-and-see and less time-consuming treatments need to be
established.
Change in plantar fascia thickness and change in FHSQ pain were
not associated, which is similar to previous findings of the lack of an
association between pain, function, and plantar fascia thickness.54
Furthermore, plantar fascia thickness is not associated with prog-
nosis.5 This indicates that repeated ultrasonography adds very little
value to the patient and clinician alike and ultrasonography should
only be used for diagnosing.55
The conduct of the trial involved many procedures to ensure that
it generated robust results, such as randomisation, sample size
calculation, concealed allocation, intention-to-treat analysis, and
prospective registration. Also, by blinding participants to how the
exercise program was prescribed to the opposite randomised group,
the trial should have minimised any pressure on participants to
exaggerate their improvement by knowing that they had been
randomised to a group that the investigators hoped or anticipated
would do better. The trial also had some limitations that ought to be
considered. The validity of the training diaries from which compli-
ance was estimated may be questionable, because patients tend to
overestimate their physical activity level and exercise compli-
ance.56,57 In addition, patients may also have difficulties with repli-
cating the exercise with an exactly correct technique when
performing exercises at home.58 Conceivably, these issues would have
applied equally to both groups and would therefore be unlikely to
strongly bias the inferences made from the data. Another limitation
was that the treating therapist was not blinded to group allocation,
which could have introduced bias when participants were instructed.
To account for this, the patient education and instructions were
standardised. Finally, musculoskeletal pain conditions involve a
complexity of biopsychosocial aspects; hence, there may be some
aspects of plantar fasciopathy that this trial did not embrace.
In conclusion, advising people with plantar fasciopathy to self-
dose their slow-heavy resistance training regimen does not sub-
stantially increase the dose achieved. Self-dosed and pre-determined
heavy-slow resistance exercise programs are associated with similar
effects on plantar fasciopathy pain and other outcomes over 12
weeks. These regimens are not sufficient to achieve acceptable
symptom state in the majority of people with plantar fasciopathy.What was already known on this topic: Heavy-slow resis-
tance training involves repeated slow contractions through
concentric, isometric and eccentric phases against a heavy load.
Heavy-slow resistance training is often used for tendinopathies.
Prelminary evidence suggests that heavy-slow resistance
training may be more effective than stretching in plantar fasci-
opathy, but the dose tested was lower than that typically used
for other tendinopathies.
What this study adds: Advising people with plantar fasciop-
athy to self-dose their slow-heavy resistance training regimen
does not substantially increase the achieved dose compared with
prescribing a pre-determined regimen. Self-dosed and pre-
determined heavy-slow resistance exercise programs are asso-
ciated with similar effects on plantar fasciopathy pain and other
outcomes over 12 weeks.Downloaded for Anonymous User (n/a) at Aalborg Hospi
For personal use only. No other uses without permissioFootnotes: a SPSS Statistics forWindows, Version 25, IBM, Armonk,
USA.
eAddenda: Table 5 and Appendix 1 can be found online at: https://
doi.org/10.1016/j.jphys.2019.05.011.
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